Nicholas A. Saccomano

Insider Reports History

Location
3200 Walnut Street, Boulder, CO
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas A. Saccomano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OnKure Therapeutics, Inc. President and CEO, Director Class A Common Stock 3.51K $9.2K $2.62 Sep 22, 2025 Direct
OnKure Therapeutics, Inc. President and CEO, Director Employee Stock Option (right to buy) 130K Jan 27, 2025 Direct

Insider Reports Filed by Nicholas A. Saccomano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Sep 22, 2025 1 -$231 4 Sep 24, 2025 President and CEO, Director
OKUR OnKure Therapeutics, Inc. Jun 23, 2025 1 -$210 4 Jun 25, 2025 President and CEO, Director
OKUR OnKure Therapeutics, Inc. Apr 4, 2025 2 -$2.57K 4 Apr 8, 2025 President and CEO, Director
OKUR OnKure Therapeutics, Inc. Jan 27, 2025 1 $0 4 Jan 29, 2025 President and CEO, Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 6 $0 4 Oct 8, 2024 President and CEO, Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 President and CEO, Director